The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial

BACKGROUND: Adequate monitoring tools are required to optimise the immunosuppressive therapy of an individual patient. Particularly, in calcineurin inhibitors, as critical dose drugs with a narrow therapeutic range, the optimal monitoring strategies are discussed in terms of safety and efficacy. Nev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerer, Claudia, Schaier, Matthias, Morath, Christian, Schwenger, Vedat, Rauch, Geraldine, Giese, Thomas, Zeier, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301857/
https://www.ncbi.nlm.nih.gov/pubmed/25494823
http://dx.doi.org/10.1186/1745-6215-15-489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301857/
https://www.ncbi.nlm.nih.gov/pubmed/25494823
http://dx.doi.org/10.1186/1745-6215-15-489

Ejemplares similares